Adline Chem Lab Ltd

NSE: KAMRON · BSE: 524604 · Pharmaceuticals & Biotechnology · 14 announcements

Share price: ₹15.79
Market cap: ₹9.24 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹-0.28 Cr
P/E (TTM): -48.7×Sector 47.4×
Promoter holding: 25.85%+0.00% QoQ
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Other Announcement 3 Financial Results 3 Board Meeting Date 3 Management Change 2 Debt & Borrowing 1 Board Meeting Outcome 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

30 Apr 2026 16:51 IST BSE

Debt & Borrowing

Adline Chem Lab Debt & Borrowing

Adline Chem Lab Ltd confirmed it does not meet the 'Large Corporate' criteria for the financial year ended March 31, 2026. Consequently, the company has no mandatory requirement to raise funds through debt securities. The filing reports nil incremental borrowings and zero shortfall in debt-sourcing obligations for the two-year block period.

Read the filing ↗